Table 1.
Baseline characteristics of participants included in PIAAF-PPS analysis
| Participant characteristics | n (%) n = 535 |
|---|---|
| Age: Mean (SD) | 75.4 (6.8) |
| Female participants | 301 (56.3) |
| Smoker | 32 (6.0) |
| Known atrial fibrillation | 8 (1.5) |
| History of hypertension | 299 (55.9) |
| High blood pressure at time of screening | 160 (29.9) |
| Known diabetes mellitus | 120 (22.4) |
| History of heart failure | 19 (3.6) |
| History of vascular artery disease | 64 (12.0) |
| History of stroke or TIA | 48 (9.0) |
| Participants with polypharmacy (≥ 4 medications)a | 237 (48.3) |
| Mean (SD) number of medications | 4.4 (3.3) |
| Participants who received any pharmacy service within 1 year prior to screening | 351 (66.6) |
| Participants eligible for annual-only medication review on day of screening or within 3 months post-screening | 194 (36.3) |
| Participants with ≥ 1 high risk medicationa | 192 (39.1) |
aN = 491 participants with available medication data